These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6879126)

  • 1. [Drug therapy of hyperprolactinemia and acromegaly].
    Staub JJ; Althaus B; Wiggli U; Gratzl O
    Schweiz Med Wochenschr; 1983 May; 113(20):733-8. PubMed ID: 6879126
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of lanreotide on prolactin level in patients with pituitary mixed tumors].
    Wasko R; Sawicka J; Stachowiak C; Kozak W; Junik R; Sowinski J
    Ann Endocrinol (Paris); 2002 Dec; 63(6 Pt 1):532-5. PubMed ID: 12527855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy: Bromocriptine.
    Parkes D
    N Engl J Med; 1979 Oct; 301(16):873-8. PubMed ID: 384250
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bromocriptine therapy of prolactinoma and hyperprolactinemia].
    Wu JZ
    Zhonghua Nei Ke Za Zhi; 1983 Oct; 22(10):611-4. PubMed ID: 6673930
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of hypophyseal tumors].
    Althoff PH; Schöffling K
    Internist (Berl); 1985 May; 26(5):280-92. PubMed ID: 3924851
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug and radiotherapy of pituitary tumors].
    Yoshida H; Takeda F; Kinouchi T; Shimizu N
    Nihon Rinsho; 1986 Mar; 44(3):659-66. PubMed ID: 3016373
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of prolactinomas and growth hormone-producing adenomas with an injectable bromocriptine retard preparation and a somatostatin analogue delivered by an implantable pump.
    Schatz H; Stracke H; Hildebrandt G
    Pathol Res Pract; 1988 Sep; 183(5):546-51. PubMed ID: 3237541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy of hyperprolactinemia and acromegaly].
    von Werder K; Eversmann T; Fahlbusch R; Rjosk HK
    Acta Med Austriaca; 1978; 5(3):61-3. PubMed ID: 377884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy of pituitary tumors].
    Hesch RD; Wagner TO
    Dtsch Med Wochenschr; 1982 Jun; 107(23):883-6. PubMed ID: 6282556
    [No Abstract]   [Full Text] [Related]  

  • 10. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
    Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
    Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting injectable bromocriptine treatment for macroprolactinomas.
    Van Cutsem EJ; Lamberts SW
    Neth J Med; 1988 Apr; 32(3-4):112-7. PubMed ID: 3362265
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parlodel. Mechanism of action and use].
    Marova EI; Egart FM; Pronin VS; Mel'nichenko GA
    Probl Endokrinol (Mosk); 1985; 31(3):85-92. PubMed ID: 3903743
    [No Abstract]   [Full Text] [Related]  

  • 13. Bromocriptine in the medical management of acromegaly.
    Besser GM; Wass JA; Thorner MO
    Adv Biochem Psychopharmacol; 1980; 23():191-8. PubMed ID: 6249090
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bromocryptin in obstetrics and gynecology].
    Alipov VI; Beskrovnaia NI
    Akush Ginekol (Mosk); 1980 Jul; (7):3-6. PubMed ID: 6998309
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia.
    Ciccarelli E; Ghigo E; Mazza E; Andreis M; Massara F; Lancranjan I; Camanni F
    J Endocrinol Invest; 1987 Apr; 10(2):179-82. PubMed ID: 3584856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine update.
    Borowski GD; Rose LI
    Am Fam Physician; 1984 Aug; 30(2):218-20. PubMed ID: 6464960
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
    Lamberts SW; de Quijada M; Klijn JG
    J Endocrinol Invest; 1980; 3(4):343-7. PubMed ID: 7204884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hyperprolactinemia and acromegaly with lisuride].
    Berezin M; Elchalal U; Olchovsky D
    Harefuah; 1989 Jun; 116(12):634-7. PubMed ID: 2792946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
    Bilbao I; Egaña N; García C; Olaizola I
    Endocrinol Diabetes Nutr; 2017 Dec; 64(10):564-566. PubMed ID: 29137963
    [No Abstract]   [Full Text] [Related]  

  • 20. The medical management of hormone-secreting tumors of the pituitary.
    Wass JA; Besser GM
    Annu Rev Med; 1983; 34():283-94. PubMed ID: 6305258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.